Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Education, AI and More at ASH 2024

November 25, 2024 |  

Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year’s programs, including a virtual patient simulation and collaborations with the Leukemia & Lymphoma Society. Additionally, Medscape will introduce new AI capabilities to enhance learning experiences for healthcare professionals, reinforcing their commitment to improving patient care through innovative education.

- PMLiVE

As the conference year draws to a close, Medscape is closing out the season in a big way, bringing 8 educational symposia and 3 posters to ASH 2024, as well as showcasing new AI capabilities.

Three posters are being presented on December 5, before the official start of the conference. In the first poster, Medscape is taking a retrospective look examining the impact of the programs produced for ASH 2023. The outcomes of this study showed how the programs made a difference in learners’ knowledge, competency, and confidence, as assessed by pre-and post-education questions. Attendees who are interested in simulation can check out Medscape’s second poster, which looks at the impact of a Medscape virtual patient simulation on cold agglutinin disease. Medscape’s third poster, on BTK inhibitors for chronic lymphocytic leukemia and mantle cell lymphoma, was created through the collaboration with The Leukemia & Lymphoma Society, a renowned patient advocacy group.

“It’s always so inspiring to look back at some of our education efforts over the past year and see how much of an impact they made. We’re proud to have worked with the Leukemia & Lymphoma Society to analyze and present the impact of some of our education in chronic lymphocytic leukemia and mantle cell lymphoma and show how education is making a difference,” said Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy, Medscape Oncology Global and leader of Medscape’s Patient-Integration Initiative.

The 8 educational symposia for 2024 will cover the following topics:

All symposia offer the ability to engage with the faculty as well as send notes and slides. Programs will be made available on Medscape.org following the conference.
New for 2024, Medscape will showcase AI features at their booth, allowing attendees to take a glimpse into the powerful ways Medscape is harnessing this technology to enhance education. Conference attendees are encouraged to stop by the Medscape booth during exhibitor hours to try it for themselves.

“Our AI pilot at ASH 2024 is game-changing. We’ve partnered with Erudio Health to pilot new tools that give healthcare professionals new ways to dive into content with AI chatbots and explore real-world cases. It’s not just about better learning – it’s about smarter, faster learning. We’re committed to staying ahead in medical education. Nobody understands medical education like Medscape, and we’re not just keeping up with tech – we’re leading the charge. We’re using our expertise to make AI work for our learners. This AI pilot is just the start. We’re focused on giving healthcare professionals the best learning experience out there, because better education means better patient care.” Dr Sushant Dahiya, Executive Director, Medscape Education

For more information on hematology and oncology education at Medscape, please contact Christine Carey. For more information on patient-integration, please contact Victoria Harvey-Jones,  or for how we are harnessing AI to power learning with impact contact Dr Sushant Dahiya.

 

This content was provided by Medscape Education

Company Details

Medscape Logo

Medscape Education

Email
Website

 Latest Content from  Medscape Education 

#ShortenTheJourney

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...

Why We Must Stop Normalizing the “Pregnancy Itch”

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...

The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health

A February Focus on the Heart  While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....

AI, Agility, and Connected Impact at Alliance 2026

Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...

Why Sleep Health is the Missing Link in Women’s Wellness

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...